National Health Investors Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

National Health Investors hat ein Gesamteigenkapital von $1.2B und eine Gesamtverschuldung von $1.1B, wodurch sich der Verschuldungsgrad auf 91.1% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $2.5B bzw. $1.2B. National Health Investors Das EBIT des Unternehmens beträgt $186.3M, so dass der Zinsdeckungsgrad 3.1 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $15.6M.

Wichtige Informationen

91.1%

Verhältnis von Schulden zu Eigenkapital

US$1.14b

Verschuldung

Zinsdeckungsgrad	3.1x
Bargeld	US$15.55m
Eigenkapital	US$1.25b
Gesamtverbindlichkeiten	US$1.21b
Gesamtvermögen	US$2.46b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

Feb 21

6%-Yielding National Health Investors: No Pain, No Gain

Feb 06

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Sep 10

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: NHIDie kurzfristigen Aktiva des Unternehmens ($122.2M) übersteigen seine kurzfristigen Passiva ($72.2M).

Langfristige Verbindlichkeiten: NHIDie kurzfristigen Vermögenswerte des Unternehmens ($122.2M) decken seine langfristigen Verbindlichkeiten ($1.1B) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: NHIDie Nettoverschuldung im Verhältnis zum Eigenkapital (89.8%) wird als hoch angesehen.

Schulden abbauen: NHI Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 99.4% auf 91.1% zurückgegangen.

Schuldendeckung: NHIDie Schulden des Unternehmens sind nicht ausreichend durch den operativen Cashflow (17.9%) gedeckt.

Zinsdeckung: NHIDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (3.1x Coverage) gut gedeckt.

National Health Investors Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Third quarter dividend of US$0.90 announced

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024

National Health Investors, Inc. to Report Q3, 2024 Results on Nov 05, 2024

National Health Investors: From Struggles To Strength

Senior VP & Chief Transaction Officer exercised options and sold US$752k worth of stock

Upcoming dividend of US$0.90 per share

Executive VP of Finance exercised options and sold US$1.3m worth of stock

Executive VP & Chief Investment Officer exercised options and sold US$1.9m worth of stock

Price target increased by 12% to US$78.50

Independent Director exercised options to buy US$767k worth of stock.

New minor risk - Shareholder dilution

National Health Investors, Inc. has completed a Follow-on Equity Offering in the amount of $171 million.

National Health Investors, Inc. has filed a Follow-on Equity Offering.

Second quarter dividend of US$0.90 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024

Independent Director exercised options and sold US$656k worth of stock

National Health Investors, Inc. to Report Q2, 2024 Results on Aug 06, 2024

National Health Investors, Inc.(NYSE:NHI) dropped from Russell Small Cap Comp Growth Index

Land & Buildings Investment Management Comments on National Health Investors’ Supplemental Proxy Statement

First quarter dividend of US$0.90 announced

National Health Investors: The Lack Of Upside Seems Obvious To Me Here

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.90 per share

Price target increased by 7.2% to US$62.00

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Price target increased by 7.5% to US$59.86

Fourth quarter dividend of US$0.90 announced

National Health: Lots To Love, But Valuation Still On The High Side

Full year 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

Catch The Senior Housing Rebound With National Health Investors

National Health Investors: 7% Yielding REIT Has Improved On Most Metrics

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

National Health Investors: Enjoy This Solid 7%+ Yield, For Now

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

National Health: What We Got Wrong With This Healthcare REIT

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings: EPS misses analyst expectations

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

6%-Yielding National Health Investors: No Pain, No Gain

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Upcoming dividend of US$0.90 per share

Independent Director recently bought US$57k worth of stock

National Health Investors, Inc. (NYSE:NHI) acquired Bickford of Virginia Beach from Bickford Senior Living, L.L.C. for $14 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Fourth Quarter 2022 Dividend, Payable on January 27, 2023

Consensus EPS estimates fall by 21%

National Health Investors, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Upcoming dividend of US$0.90 per share

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Chief Investment Officer exercised options and sold US$220k worth of stock

Price target increased to US$62.71

Independent Director recently bought US$99k worth of stock

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz